AMPK alpha 2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-49859
Key Product Details
Species Reactivity
Validated:
Human, Mouse, Rat
Predicted:
Bovine (100%), Canine (100%), Porcine (100%). Backed by our 100% Guarantee.
Applications
Peptide ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence CPLDALNTTKP, from the internal region of the protein sequence according to NP_006243.2.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for AMPK alpha 2 Antibody
Western Blot: AMPK alpha 2 Antibody [NBP1-49859]
Western Blot: AMPK alpha 2 Antibody [NBP1-49859] - Staining of Mouse (A) and Rat (B) Heart lysate (35 ug protein in RIPA buffer). Antibody at 0.3 ug/mL. Primary incubation was 1 hour. Detected by chemiluminescence.Western Blot: AMPK alpha 2 Antibody [NBP1-49859]
Western Blot: AMPK alpha 2 Antibody [NBP1-49859] - Staining of Human Liver lysate (35 ug protein in RIPA buffer). Antibody at 1 ug/mL. Primary incubation was 1 hour. Detected by chemiluminescence.Applications for AMPK alpha 2 Antibody
Application
Recommended Usage
Peptide ELISA
1:16000
Western Blot
0.3 - 1 ug/mL
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: AMPK alpha 2
Long Name
AMP-activated Protein Kinase alpha
Alternate Names
PRKAA2
Gene Symbol
PRKAA2
UniProt
Additional AMPK alpha 2 Products
Product Documents for AMPK alpha 2 Antibody
Product Specific Notices for AMPK alpha 2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...